Showing results (621-630 of 11,908) with videos related to

Sort By:
Pageof 1,191
The New England Journal of Medicine|April 23, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
The New England Journal of Medicine|May 2, 2020
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19Harmony R Reynolds, Samrachana Adhikari, Claudia Pulgarin, et al.
The New England Journal of Medicine|September 17, 2021
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung CancerBob T Li, Egbert F Smit, Yasushi Goto, et al.
The New England Journal of Medicine|May 8, 2020
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Yifei Sun, Jonathan Platt, et al.
The New England Journal of Medicine|May 30, 2020
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping MutationsPaul K Paik, Enriqueta Felip, Remi Veillon, et al.
The New England Journal of Medicine|April 29, 2021
Tranexamic Acid for the Prevention of Blood Loss after Cesarean DeliveryLoïc Sentilhes, Marie V Sénat, Maëla Le Lous, et al.
The New England Journal of Medicine|August 24, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple SclerosisLawrence Steinman, Edward Fox, Hans-Peter Hartung, et al.
The New England Journal of Medicine|August 24, 2022
Olokizumab versus Placebo or Adalimumab in Rheumatoid ArthritisJosef S Smolen, Eugen Feist, Saeed Fatenejad, et al.
The New England Journal of Medicine|November 7, 2022
Trial of an Intervention to Improve Acute Heart Failure OutcomesDouglas S Lee, Sharon E Straus, Michael E Farkouh, et al.
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
Pageof 1,191